Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

671
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
671
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

719
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
719
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

377
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
377
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

928
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
928
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

460
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
460
Stimulants01:29

Stimulants

770
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
770

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Teratoma to Angiosarcoma: A Metamorphosis in the Mediastinum.

Cureus·2024
Same author

Application of the RE-AIM framework to evaluate the implementation of telehealth pulmonary rehabilitation in a randomized controlled trial among African-American and Hispanic patients with advanced stage Chronic Obstructive Pulmonary Disease.

BMC health services research·2023
Same author

Randomized Open Investigation Determining Steroid Dose in Severe COVID-19: The ROIDS-Dose Clinical Trial.

Cureus·2022
Same author

Attenuation of Human Growth Hormone-Induced Rash With Graded Dose Challenge.

Cureus·2022
Same author

Association of hypoglossal nerve stimulator response with machine learning identified negative effort dependence patterns.

Sleep & breathing = Schlaf & Atmung·2022
Same author

Transesophageal Lung Ultrasonography as Part of the Critical Care Transesophageal Echocardiography Examination.

Chest·2022

Related Experiment Video

Updated: Dec 26, 2025

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

3.7K

Acute Respiratory Failure Associated With Vaping.

Craig Fryman1, Becky Lou1, Andrew G Weber1

  • 1Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY.

Chest
|March 9, 2020
PubMed
Summary
This summary is machine-generated.

Vaping, especially with marijuana products, can cause acute lung injury and respiratory failure in young adults. This case series details the clinical and pathological findings of this emerging vaping-associated pulmonary disease.

Keywords:
interstitial lung diseasemarijuanapulmonaryrespiratory failuresmoking

More Related Videos

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

26.2K
Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

11.9K

Related Experiment Videos

Last Updated: Dec 26, 2025

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

3.7K
Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

26.2K
Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

11.9K

Area of Science:

  • Pulmonology
  • Toxicology
  • Public Health

Background:

  • E-cigarette use for nicotine delivery is increasing.
  • Reports link vaping to acute pulmonary disease from nicotine and marijuana products.
  • Marijuana use is rising with evolving policies.

Purpose of the Study:

  • To describe clinical, radiographic, and histopathologic features of lung injury from vaping marijuana products.
  • To characterize acute respiratory failure associated with vaping.
  • To provide insight into the potential lung toxicity of vaping.

Main Methods:

  • Case series of eight patients admitted with acute respiratory failure after vaping.
  • Analysis of clinical presentation, radiographic imaging, and histopathologic findings.
  • Focus on patients predominantly using marijuana-based products.

Main Results:

  • Most patients were young (median age 31.5 years) with no prior lung disease.
  • Presented with acute respiratory failure following vaping.
  • Common clinical findings with varied radiographic and histopathologic features observed.

Conclusions:

  • Vaping, particularly marijuana-based products, is associated with acute pulmonary injury.
  • Further data is needed to fully characterize this emerging disease.
  • Understanding pathogenesis and clinical course is crucial for optimal patient management.